An Eastern Cooperative Oncology Group phase II trial of trimetrexate in the treatment of advanced urothelial carcinoma.
Scher
H I
HI
D002295:Carcinoma, Transitional Cell / Q000188:drug therapy*; D006801:Humans; D016597:Trimetrexate / Q000627:therapeutic use*; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*
D016597:Trimetrexate